Conversations with clinical trial professionals exploring vendor management, quality oversight, and the evolving regulatory landscape. Hosted by Tom Lazenby.https://mayetrx.com/https://mayetrx.com/podcast/ep20-tabakin/https://mayetrx.com/podcast/ep20-tabakin/Tom and Dudley discuss why the sensor is the last thing you should choose, how to work backward from a patient-meaningful measure to the device and the algorithm, and why clinical validation — not the technology — is the real regulatory hurdle.Fri, 04 Sep 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep19-dorricott/https://mayetrx.com/podcast/ep19-dorricott/Tom and Keith discuss how to build clinical trial metrics that measure what matters, why performative metrics look good on a slide and tell you nothing, and how vague definitions turn a dashboard into an argument nobody can win.Fri, 21 Aug 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep18-grimes/https://mayetrx.com/podcast/ep18-grimes/Tom and Brad discuss device provisioning for decentralised trials, why connectivity rather than the device is where trials break, and the downstream costs hiding behind two words: pass-through.Fri, 07 Aug 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep17-titkova/https://mayetrx.com/podcast/ep17-titkova/Tom and Anna discuss running clinical trial sites through crisis, why enrolment numbers are a lagging indicator, and what genuine patient-centricity costs when it becomes a decision rather than a slide.Fri, 24 Jul 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep16-jackson/https://mayetrx.com/podcast/ep16-jackson/Tom and Ross discuss why patient recruitment fails, the growing role of AI in recruitment, and why sponsors need to take active ownership of their recruitment strategies.Fri, 10 Jul 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep15-jones/https://mayetrx.com/podcast/ep15-jones/Tom and Matt discuss the shift to risk-based validation, the growing role of AI in pharma, red flags auditors should watch for, and effective IT vendor management.Fri, 26 Jun 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep14-lakhani/https://mayetrx.com/podcast/ep14-lakhani/Tom and Ricky discuss the cost of disconnected systems in clinical trials, quality by design principles, and the Mayet-PHARMASEAL integration partnership.Fri, 12 Jun 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep13-obalampalli/https://mayetrx.com/podcast/ep13-obalampalli/Tom and Kalyan discuss vendor selection challenges, the financial consequences of poor vendor choices, and practical tips for smaller biotech companies.Fri, 29 May 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep12-mcmanus/https://mayetrx.com/podcast/ep12-mcmanus/Tom and Barry discuss managing technology vendors, the critical role of risk assessment in validation, and myth-busting common misconceptions about compliance.Fri, 15 May 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep11-hersch-crow/https://mayetrx.com/podcast/ep11-hersch-crow/Part two continues with vendor off-boarding, closeout best practices, proactive risk management, and the role of technology in strengthening CRO relationships.Fri, 01 May 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep10-hersch-crow/https://mayetrx.com/podcast/ep10-hersch-crow/Tom, Matthew, and Stephen discuss governance in clinical trials, the vendor management lifecycle from selection to onboarding, and building trust with CRO partners.Fri, 17 Apr 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep9-lazenby/https://mayetrx.com/podcast/ep9-lazenby/In this special episode, Kalyan interviews Tom about the journey of building Mayet, the importance of integrity in business, and the future of vendor management software.Fri, 03 Apr 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep8-ellis/https://mayetrx.com/podcast/ep8-ellis/Tom and Carl discuss the intricacies of procurement in clinical trials, including stakeholder relationships, balancing cost and quality, and practical tips for transparency.Fri, 20 Mar 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep7-debie/https://mayetrx.com/podcast/ep7-debie/Tom and Henrieke explore the intersection of behavioural science and quality management, including psychological safety, accountability, and building quality culture across organisations.Fri, 06 Mar 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep6-berelowitz/https://mayetrx.com/podcast/ep6-berelowitz/Tom and Keith explore how patient engagement reshapes service provider selection, the role of patient feedback in trial delivery, and the future of patient-centric approaches.Fri, 20 Feb 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep5-ortland/https://mayetrx.com/podcast/ep5-ortland/Tom and Christoph discuss the unique challenges small sponsors face with regulatory compliance, risk management, and the growing importance of digital tools.Fri, 06 Feb 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep4-enever/https://mayetrx.com/podcast/ep4-enever/Tom and Yvanne discuss building quality partnerships between sponsors and CROs, balancing academic and commercial needs, and preparing for GCP Revision 3.Fri, 23 Jan 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep3-barthel/https://mayetrx.com/podcast/ep3-barthel/Tom and Virginie explore how digitalisation and software adoption can simplify clinical operations, improve trial timelines, and reduce manual tasks.Fri, 09 Jan 2026 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep2-burmester/https://mayetrx.com/podcast/ep2-burmester/Tom and Jo discuss best practices for vendor selection, ensuring GCP compliance, and strategies for managing vendor risk while avoiding common pitfalls.Fri, 26 Dec 2025 15:05:22 GMTTom Lazenbyhttps://mayetrx.com/podcast/ep1-doucet/https://mayetrx.com/podcast/ep1-doucet/Tom and Smaranda explore actionable tactics for effective sponsor oversight and the impact of ICH GCP Revision 3 on how sponsors manage their responsibilities.Fri, 12 Dec 2025 15:05:22 GMTTom Lazenby